{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:12:41Z","timestamp":1788484361791,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sponsored by Natural Science Foundation of Xinjiang Uygur Autonomous Region","award":["2025D01E42"],"award-info":[{"award-number":["2025D01E42"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260071"],"award-info":[{"award-number":["82260071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-026-03002-4","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T06:45:07Z","timestamp":1782197107000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factor analysis of early-onset dyslipidemia-a cross-sectional study of 3.7\u00a0million population"],"prefix":"10.1186","volume":"25","author":[{"given":"Fen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoguo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"1","key":"3002_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJMe1914757","volume":"382","author":"LR Wechsler","year":"2020","unstructured":"Wechsler LR. Statins and Stroke - It\u2019s Complicated. N Engl J Med. 2020;382(1):81\u20132.","journal-title":"N Engl J Med"},{"issue":"1","key":"3002_CR2","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12872-023-03399-1","volume":"23","author":"N Ali","year":"2023","unstructured":"Ali N, Kathak RR, Fariha KA, Taher A, Islam F. Prevalence of dyslipidemia and its associated factors among university academic staff and students in Bangladesh. BMC Cardiovasc Disord. 2023;23(1):366.","journal-title":"BMC Cardiovasc Disord"},{"issue":"10","key":"3002_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41569-021-00541-4","volume":"18","author":"A Pirillo","year":"2021","unstructured":"Pirillo A, Casula M, Olmastroni E, Norata GD, Catapano AL. Global epidemiology of dyslipidaemias. Nat Rev Cardiol. 2021;18(10):689\u2013700.","journal-title":"Nat Rev Cardiol"},{"key":"3002_CR4","doi-asserted-by":"publisher","first-page":"249584","DOI":"10.1155\/2014\/249584","volume":"2014","author":"W Aekplakorn","year":"2014","unstructured":"Aekplakorn W, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Putwatana P, Sritara P, et al. Prevalence of Dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009. J Lipids. 2014;2014:249584.","journal-title":"J Lipids"},{"issue":"8","key":"3002_CR5","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93\u2013621.","journal-title":"Circulation"},{"issue":"7","key":"3002_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/jclinpath-2019-205910","volume":"73","author":"RA Sulaiman","year":"2020","unstructured":"Sulaiman RA. Inherited metabolic disorders and dyslipidaemia. J Clin Pathol. 2020;73(7):384\u201390.","journal-title":"J Clin Pathol"},{"key":"3002_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-981-15-1792-1_5","volume":"1228","author":"N He","year":"2020","unstructured":"He N, Ye H. Exercise and Hyperlipidemia. Adv Exp Med Biol. 2020;1228:79\u201390.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"3002_CR8","doi-asserted-by":"publisher","first-page":"19475","DOI":"10.1038\/s41598-019-55480-5","volume":"9","author":"J Abuzhalihan","year":"2019","unstructured":"Abuzhalihan J, Wang YT, Adi D, Ma YT, Fu ZY, Yang YN, et al. Prevalence of Dyslipidemia in Students from Han, Uygur, and Kazakh Ethnic Groups in a Medical University in Xinjiang, China. Sci Rep. 2019;9(1):19475.","journal-title":"Sci Rep"},{"issue":"3","key":"3002_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3390\/biomedicines11030809","volume":"11","author":"F La Mainieri","year":"2023","unstructured":"Mainieri F, La Bella S, Chiarelli F. Hyperlipidemia and Cardiovascular Risk in Children and Adolescents. Biomedicines. 2023;11(3):809.","journal-title":"Biomedicines"},{"issue":"1","key":"3002_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12944-022-01721-y","volume":"21","author":"Z Li","year":"2022","unstructured":"Li Z, Zhu G, Chen G, Luo M, Liu X, Chen Z, et al. Distribution of lipid levels and prevalence of hyperlipidemia: data from the NHANES 2007\u20132018. Lipids Health Dis. 2022;21(1):111.","journal-title":"Lipids Health Dis"},{"key":"3002_CR11","doi-asserted-by":"publisher","first-page":"e19344","DOI":"10.7717\/peerj.19344","volume":"13","author":"G Maimaitituersun","year":"2025","unstructured":"Maimaitituersun G, Jureti S, Yi Z, Zhou Y, Li M, Wei M, et al. Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study. PeerJ. 2025;13:e19344.","journal-title":"PeerJ"},{"issue":"4","key":"3002_CR12","first-page":"313","volume":"36","author":"M Zhang","year":"2023","unstructured":"Zhang M, Peng K, Zhang X, Liu YS, Liu XY, Han GY, et al. Geographic Variations in the Prevalence, Awareness, Treatment, and Control of Dyslipidemia among Chinese Adults in 2018\u20132019: A Cross-sectional Study. Biomed Environ Sci. 2023;36(4):313\u201323.","journal-title":"Biomed Environ Sci"},{"issue":"1","key":"3002_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12944-022-01691-1","volume":"21","author":"J Li","year":"2022","unstructured":"Li J, Nie Z, Ge Z, Shi L, Gao B, Yang Y. Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study. Lipids Health Dis. 2022;21(1):77.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3002_CR14","first-page":"57","volume":"43","author":"Y Yamada","year":"2019","unstructured":"Yamada Y, Kato K, Oguri M, Horibe H, Fujimaki T, Yasukochi Y, et al. Identification of 12 novel loci that confer susceptibility to early-onset dyslipidemia. Int J Mol Med. 2019;43(1):57\u201382.","journal-title":"Int J Mol Med"},{"issue":"2","key":"3002_CR15","doi-asserted-by":"publisher","first-page":"e003816","DOI":"10.1161\/CIRCGEN.122.003816","volume":"16","author":"O Dikilitas","year":"2023","unstructured":"Dikilitas O, Sherafati A, Saadatagah S, Satterfield BA, Kochan DC, Anderson KC, et al. Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results. Circ Genom Precis Med. 2023;16(2):e003816.","journal-title":"Circ Genom Precis Med"},{"issue":"19","key":"3002_CR16","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"6","key":"3002_CR17","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206\u201352.","journal-title":"Hypertension"},{"issue":"36","key":"3002_CR18","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"7","key":"3002_CR19","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539\u201353.","journal-title":"Diabet Med"},{"issue":"18","key":"3002_CR20","first-page":"1387","volume":"105","author":"MY Li","year":"2025","unstructured":"Li MY, Luo YY, Zhang P, Chen W, Zhang YQ, Fang ZZ, et al. [Interpretation of national clinical practice guideline on obesity management (2024 edition)]. Zhonghua Yi Xue Za Zhi. 2025;105(18):1387\u201391.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"3002_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2016.02.006","volume":"248","author":"L Pan","year":"2016","unstructured":"Pan L, Yang Z, Wu Y, Yin RX, Liao Y, Wang J, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis. 2016;248:2\u20139.","journal-title":"Atherosclerosis"},{"key":"3002_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-511X-13-4","volume":"13","author":"JY Luo","year":"2014","unstructured":"Luo JY, Ma YT, Yu ZX, Yang YN, Xie X, Ma X, et al. Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey. Lipids Health Dis. 2014;13:4.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3002_CR23","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1038\/s41598-021-96864-w","volume":"11","author":"C Huang","year":"2021","unstructured":"Huang C, Zhang WQ, Tang WW, Liu Y, Liu JX, Xu RH, et al. Prevalence and related factors of dyslipidemia among urban adults aged 35 to 79 years in Southwestern China. Sci Rep. 2021;11(1):17579.","journal-title":"Sci Rep"},{"issue":"24","key":"3002_CR24","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.2174\/0929867321666140303123602","volume":"21","author":"M Pellegrini","year":"2014","unstructured":"Pellegrini M, Pallottini V, Marin R, Marino M. Role of the sex hormone estrogen in the prevention of lipid disorder. Curr Med Chem. 2014;21(24):2734\u201342.","journal-title":"Curr Med Chem"},{"issue":"1","key":"3002_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1152\/physrev.00033.2011","volume":"93","author":"A Tchernof","year":"2013","unstructured":"Tchernof A, Despr\u00e9s JP. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013;93(1):359\u2013404.","journal-title":"Physiol Rev"},{"key":"3002_CR26","doi-asserted-by":"publisher","first-page":"109924","DOI":"10.1016\/j.diabres.2022.109924","volume":"188","author":"JJ Noubiap","year":"2022","unstructured":"Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, Nkeck JR, Nyaga UF, Ngouo AT, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract. 2022;188:109924.","journal-title":"Diabetes Res Clin Pract"},{"issue":"39","key":"3002_CR27","doi-asserted-by":"publisher","first-page":"e39692","DOI":"10.1097\/MD.0000000000039692","volume":"103","author":"M Fu","year":"2024","unstructured":"Fu M, Yang D, Luo Y, Zou Y. Dietary patterns and metabolic syndrome amongst adult residents: A cross-sectional study in a rapidly urbanized Southern Chinese city. Medicine. 2024;103(39):e39692.","journal-title":"Medicine"},{"issue":"7","key":"3002_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","volume":"14","author":"\u017d Reiner","year":"2017","unstructured":"Reiner \u017d. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14(7):401\u201311.","journal-title":"Nat Rev Cardiol"},{"issue":"29","key":"3002_CR29","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.2174\/0929867328666210208182326","volume":"28","author":"S Ganjali","year":"2021","unstructured":"Ganjali S, Watts GF, Banach M, Reiner \u017d, Nachtigal P, Sahebkar A. The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis. Curr Med Chem. 2021;28(29):6066\u201381.","journal-title":"Curr Med Chem"},{"issue":"9","key":"3002_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11883-024-01225-3","volume":"26","author":"G Bosco","year":"2024","unstructured":"Bosco G, Mszar R, Piro S, Sabouret P, Gallo A. Cardiovascular Risk Estimation and Stratification Among Individuals with Hypercholesterolemia. Curr Atheroscler Rep. 2024;26(9):537\u201348.","journal-title":"Curr Atheroscler Rep"},{"issue":"3","key":"3002_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/MOL.0000000000000926","volume":"35","author":"SE van den Bosch","year":"2024","unstructured":"van den Bosch SE, Hutten BA, Corpeleijn WE, Kusters DM. Familial hypercholesterolemia in children and the importance of early treatment. Curr Opin Lipidol. 2024;35(3):126\u201332.","journal-title":"Curr Opin Lipidol"},{"issue":"36","key":"3002_CR32","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","volume":"36","author":"A Wiegman","year":"2015","unstructured":"Wiegman A, Gidding SS, Watts GF, Chapman MJ, Ginsberg HN, Cuchel M, et al. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur Heart J. 2015;36(36):2425\u201337.","journal-title":"Eur Heart J"},{"issue":"8033","key":"3002_CR33","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-024-07993-x","volume":"634","author":"M Takaoka","year":"2024","unstructured":"Takaoka M, Zhao X, Lim HY, Magnussen CG, Ang O, Suffee N, et al. Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis. Nature. 2024;634(8033):457\u201365.","journal-title":"Nature"},{"issue":"19","key":"3002_CR34","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","volume":"134","author":"X Yang","year":"2016","unstructured":"Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation. 2016;134(19):1430\u201340.","journal-title":"Circulation"},{"issue":"12","key":"3002_CR35","doi-asserted-by":"publisher","first-page":"e075860","DOI":"10.1136\/bmjopen-2023-075860","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Du J, Zhou N, Song Y, Wang W, Hong X. Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China. BMJ Open. 2023;13(12):e075860.","journal-title":"BMJ Open"},{"key":"3002_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.12.069","volume":"260","author":"M Zhang","year":"2018","unstructured":"Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196\u2013203.","journal-title":"Int J Cardiol"},{"key":"3002_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.puhe.2018.01.003","volume":"157","author":"XX Li","year":"2018","unstructured":"Li XX, Zhao Y, Huang LX, Xu HX, Liu XY, Yang JJ, et al. Effects of smoking and alcohol consumption on lipid profile in male adults in northwest rural China. Public Health. 2018;157:7\u201313.","journal-title":"Public Health"},{"issue":"12","key":"3002_CR38","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.numecd.2020.07.032","volume":"30","author":"L Xing","year":"2020","unstructured":"Xing L, Jing L, Tian Y, Yan H, Zhang B, Sun Q, et al. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study. Nutr Metab Cardiovasc Dis. 2020;30(12):2262\u201370.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"3002_CR39","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41598-022-04968-8","volume":"12","author":"N Tang","year":"2022","unstructured":"Tang N, Ma J, Tao R, Chen Z, Yang Y, He Q, et al. The effects of the interaction between BMI and dyslipidemia on hypertension in adults. Sci Rep. 2022;12(1):927.","journal-title":"Sci Rep"},{"issue":"2","key":"3002_CR40","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3390\/ijerph20020982","volume":"20","author":"J Wyszy\u0144ska","year":"2023","unstructured":"Wyszy\u0144ska J, \u0141uszczki E, Sobek G, Mazur A, Dere\u0144 K. Association and Risk Factors for Hypertension and Dyslipidemia in Young Adults from Poland. Int J Environ Res Public Health. 2023;20(2):982.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"3002_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s40256-015-0128-1","volume":"15","author":"B Ivanovic","year":"2015","unstructured":"Ivanovic B, Tadic M. Hypercholesterolemia and Hypertension: Two Sides of the Same Coin. Am J Cardiovasc Drugs. 2015;15(6):403\u201314.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"12","key":"3002_CR42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s11892-018-1101-6","volume":"18","author":"P Bjornstad","year":"2018","unstructured":"Bjornstad P, Eckel RH. Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review. Curr Diab Rep. 2018;18(12):127.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"3002_CR43","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/ijerph19010341","volume":"19","author":"L Cao","year":"2021","unstructured":"Cao L, Zhou J, Chen Y, Wu Y, Wang Y, Liu T, et al. Effects of Body Mass Index, Waist Circumference, Waist-to-Height Ratio and Their Changes on Risks of Dyslipidemia among Chinese Adults: The Guizhou Population Health Cohort Study. Int J Environ Res Public Health. 2021;19(1):341.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"3002_CR44","doi-asserted-by":"publisher","first-page":"e003053","DOI":"10.1161\/JAHA.115.003053","volume":"5","author":"T Otsuka","year":"2016","unstructured":"Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, et al. Dyslipidemia and the Risk of Developing Hypertension in a Working-Age Male Population. J Am Heart Assoc. 2016;5(3):e003053.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3002_CR45","doi-asserted-by":"publisher","first-page":"e70055","DOI":"10.1002\/osp4.70055","volume":"11","author":"J Shahraz","year":"2025","unstructured":"Shahraz J, Joukar F, Sheida F, Yeganeh S, Maroufizadeh S, Baghaee M, et al. Associations Between Body Mass Index (BMI) and Dyslipidemia: Results From the PERSIAN Guilan Cohort Study (PGCS). Obes Sci Pract. 2025;11(1):e70055.","journal-title":"Obes Sci Pract"},{"issue":"8","key":"3002_CR46","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/nu10081011","volume":"10","author":"M Kuwabara","year":"2018","unstructured":"Kuwabara M, Kuwabara R, Niwa K, Hisatome I, Smits G, Roncal-Jimenez CA, et al. Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects. Nutrients. 2018;10(8):1011.","journal-title":"Nutrients"},{"issue":"10","key":"3002_CR47","doi-asserted-by":"publisher","first-page":"e0205709","DOI":"10.1371\/journal.pone.0205709","volume":"13","author":"Y Li","year":"2018","unstructured":"Li Y, Zhao L, Yu D, Ding G. The prevalence and risk factors of dyslipidemia in different diabetic progression stages among middle-aged and elderly populations in China. PLoS ONE. 2018;13(10):e0205709.","journal-title":"PLoS ONE"},{"key":"3002_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2019.01.005","volume":"282","author":"P Song","year":"2019","unstructured":"Song P, Zha M, Yang X, Xu Y, Wang H, Fang Z, et al. Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese. Atherosclerosis. 2019;282:57\u201366.","journal-title":"Atherosclerosis"},{"key":"3002_CR49","doi-asserted-by":"publisher","first-page":"878126","DOI":"10.3389\/fpubh.2022.878126","volume":"10","author":"L Li","year":"2022","unstructured":"Li L, Ouyang F, He J, Qiu D, Luo D, Xiao S. Associations of Socioeconomic Status and Healthy Lifestyle With Incidence of Dyslipidemia: A Prospective Chinese Governmental Employee Cohort Study. Front Public Health. 2022;10:878126.","journal-title":"Front Public Health"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-03002-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-03002-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:19:22Z","timestamp":1788481162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-03002-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3002"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-03002-4","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"189"}}